Novo Nordisk Aligns Brand Ozempic Price With Generics in Canada

Novo Nordisk Canada announced it will reduce the price of brand-name Ozempic for eligible Canadians without public or private drug coverage, with the discount taking effect Friday and explicitly framed as "aligning their medication costs with generic alternatives" [Source: globalnews.ca/news/11863331/novo-nordisk-slash-ozempic-price-generics/].

What Novo Nordisk announced

The reduced price will be accessed using a Novo Nordisk Savings Card, usable at local pharmacies across Canada, excluding Quebec, and applied automatically at Novo Nordisk Care Rx operated by Rexall [Source: globalnews.ca/news/11863331/novo-nordisk-slash-ozempic-price-generics/]. Iain Graham, general manager at Novo Nordisk Canada, said the company is "dedicated to ensuring that eligible patients who choose Ozempic can stay on the brand because of these additional savings" [Source: globalnews.ca/news/11863331/novo-nordisk-slash-ozempic-price-generics/].

Why now: generics have landed

The announcement follows Health Canada's approval of two generic semaglutide products — one from India-based Dr. Reddy's and one from Canadian manufacturer Apotex [Source: globalnews.ca/news/11863331/novo-nordisk-slash-ozempic-price-generics/]. Apotex began shipping its product on the day of the Novo Nordisk announcement, while Dr. Reddy's reported that its semaglutide had already arrived in "select" Canadian pharmacies, with wider availability expected in the coming days [Source: globalnews.ca/news/11863331/novo-nordisk-slash-ozempic-price-generics/].

Apotex has stated its generic semaglutide will be approximately one-third the price of Novo Nordisk's brand-name Ozempic, while a Dr. Reddy's spokesperson would say only that its pricing will be "competitive" [Source: globalnews.ca/news/11863331/novo-nordisk-slash-ozempic-price-generics/].

The price context

Global News reports that Ozempic and Wegovy currently cost hundreds of dollars a month, depending on dosage, in some cases more than $450 [Source: globalnews.ca/news/11863331/novo-nordisk-slash-ozempic-price-generics/]. The BBC reported the case of Elizabeth Doran, a 69-year-old retiree in Ottawa, who paid between C$350 and C$500 out of pocket per month for Wegovy because her prescription for weight management did not qualify her for Ontario's diabetic senior drug coverage [Source: bbc.com/news/articles/c142y4p2eyxo].

Current pharmacy prices listed on GLP1Prices.ca for Ozempic range from $215 to $663 CAD across 83 verified samples, consistent with the figures cited in the source reporting.

Coverage backdrop

GLP-1 drugs like Ozempic are usually covered for type 2 diabetes under public drug plans, but only a small number of private insurers cover the drugs for weight management [Source: globalnews.ca/news/11863331/novo-nordisk-slash-ozempic-price-generics/]. Ontario lists Ozempic as a "Limited Use drug," requiring a doctor to confirm it meets the specific needs of the patient, while Alberta treats it as a step therapy, requiring patients to try other treatments first [Source: globalnews.ca/news/11863331/novo-nordisk-slash-ozempic-price-generics/].

In December 2025, negotiations that could have led to coverage of Wegovy under Canadian public health plans broke down, with the pan-Canadian Pharmaceutical Alliance stating that talks "concluded without agreement (manufacturer declined negotiation)" [Source: globalnews.ca/news/11863331/novo-nordisk-slash-ozempic-price-generics/].

How the brand-versus-generic math works

Industry context from Endor Health notes that Health Canada requires generic medications to be pharmaceutically equivalent to brand-name drugs — containing the same active ingredient in the same strength and dosage form — and to demonstrate bioequivalence [Source: endorhealth.com/article/generic-ozempic-coming-to-canada]. Many insurance plans typically prefer or require the lower-cost generic version once available, and patients who prefer to remain on the branded version may need to pay the difference in cost [Source: endorhealth.com/article/generic-ozempic-coming-to-canada].

Wegovy in Canada is delivered using a multi-dose FlexTouch pen, with one pen containing a four-week supply [Source: walkin.ca/blog/wegovy-canada/]. Patients comparing brand versus generic options can review the generic semaglutide tracker, check eligibility with the insurance coverage checker, or visit the FAQ. Tirzepatide products Mounjaro and Zepbound from Eli Lilly remain under patent protection in Canada and are not directly affected by the semaglutide generics [Source: endorhealth.com/article/generic-ozempic-coming-to-canada]. Oral semaglutide product Rybelsus is also a Novo Nordisk product.

This article is for informational purposes only and does not constitute medical advice.